The Cochrane Library: Cochrane Database of Systematic Reviews

Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

DOI: 10.1002/14651858

Reviews/Protocols listed by Cochrane Review Group


  1. Cochrane Acute Respiratory Infections Group
  2. Cochrane Airways Group
  3. Cochrane Anaesthesia Group
  4. Cochrane Back Group
  5. Cochrane Bone, Joint and Muscle Trauma Group
  6. Cochrane Breast Cancer Group
  7. Cochrane Childhood Cancer Group
  8. Cochrane Colorectal Cancer Group
  9. Cochrane Consumers and Communication Group
  10. Cochrane Cystic Fibrosis and Genetic Disorders Group
  11. Cochrane Dementia and Cognitive Improvement Group
    1. About this group
    2. Reviews
      1. Acetyl-l-carnitine for dementiaReview
      2. Acupuncture for vascular dementiaReview
      3. Almitrine-Raubasine combination for dementiaReview
      4. Alpha lipoic acid for dementiaReview
      5. Antidepressants for agitation and psychosis in dementiaReview
      6. Antidepressants for treating depression in dementiaReview
      7. Antipsychotics for deliriumReview
      8. Aroma therapy for dementiaReview
      9. Aspirin for vascular dementiaReview
      10. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's diseaseReview
      11. Atypical antipsychotics for aggression and psychosis in Alzheimer's diseaseReview
      12. Benzodiazepines for deliriumReview
      13. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementiaReview
      14. Cannabinoids for the treatment of dementiaReview
      15. Carbohydrates for improving the cognitive performance of independent-living older adults with normal cognition or mild cognitive impairmentReview
      16. Cerebrolysin for vascular dementiaReview
      17. Cholinesterase inhibitors for Alzheimer's diseaseReview
      18. Cholinesterase inhibitors for deliriumReview
      19. Cholinesterase inhibitors for dementia with Lewy bodiesReview
      20. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's diseaseReview
      21. Cholinesterase inhibitors for mild cognitive impairmentReview
      22. Cholinesterase inhibitors for Parkinson's disease dementiaReview
      23. Cognition-based interventions for healthy older people and people with mild cognitive impairmentReview
      24. Cognitive reframing for carers of people with dementiaReview
      25. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementiaReview
      26. Cognitive stimulation to improve cognitive functioning in people with dementiaReview
      27. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderlyReview
      28. D-cycloserine for Alzheimer's diseaseReview
      29. Dehydroepiandrosterone (DHEA) supplementation for cognitive functionReviewWithdrawn
      30. Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly peopleReview
      31. Donepezil for dementia due to Alzheimer's diseaseReview
      32. Donepezil for mild cognitive impairmentReview
      33. Donepezil for vascular cognitive impairmentReview
      34. Driving assessment for maintaining mobility and safety in drivers with dementiaReview
      35. Effect of the treatment of Type II diabetes mellitus on the development of cognitive impairment and dementiaReview
      36. Enteral tube feeding for older people with advanced dementiaReview
      37. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented peopleReview
      38. Functional analysis-based interventions for challenging behaviour in dementiaReview
      39. Galantamine for Alzheimer's disease and mild cognitive impairmentReview
      40. Galantamine for vascular cognitive impairmentReviewNew Search
      41. Ginkgo biloba for cognitive impairment and dementiaReview
      42. Ginseng for cognitionReview
      43. Haloperidol for agitation in dementiaReview
      44. Homeopathy for dementiaReview
      45. Hormone replacement therapy for cognitive function in postmenopausal womenReview
      46. Hormone replacement therapy to maintain cognitive function in women with dementiaReview
      47. Huperzine A for Alzheimer's diseaseReview
      48. Huperzine A for mild cognitive impairmentReview
      49. Huperzine A for vascular dementiaReview
      50. Hydergine for dementiaReview
      51. Hyperbaric oxygen therapy for vascular dementiaReview
      52. Ibuprofen for Alzheimer's diseaseReview
      53. Indomethacin for Alzheimer's diseaseReview
      54. Interventions for preventing and reducing the use of physical restraints in long-term geriatric careReview
      55. Interventions for preventing delirium in hospitalised patientsReview
      56. Lecithin for dementia and cognitive impairmentReview
      57. Light therapy for managing cognitive, sleep, functional, behavioural, or psychiatric disturbances in dementiaReview
      58. Massage and touch for dementiaReview
      59. Melatonin for the treatment of dementiaReview
      60. Memantine for dementiaReview
      61. Metal protein attenuating compounds for the treatment of Alzheimer's dementiaReview
      62. Metrifonate for Alzheimer's diseaseReview
      63. Multidisciplinary team interventions for delirium in patients with chronic cognitive impairmentReviewWithdrawn
      64. Music therapy for people with dementiaReview
      65. Naftidrofuryl for dementiaReview
      66. Nicergoline for dementia and other age associated forms of cognitive impairmentReview
      67. Nicotine for Alzheimer's diseaseReview
      68. Nimodipine for primary degenerative, mixed and vascular dementiaReview
      69. -Non-pharmacological interventions for wandering of people with dementia in the domestic settingReview
      70. Omega 3 fatty acid for the prevention of cognitive decline and dementiaReview
      71. Physical activity and enhanced fitness to improve cognitive function in older people without known cognitive impairmentReview
      72. Physical activity programs for persons with dementiaReview
      73. Physostigmine for dementia due to Alzheimer's diseaseReview
      74. Piracetam for dementia or cognitive impairmentReview
      75. Procaine treatments for cognition and dementiaReview
      76. Propentofylline for dementiaReview
      77. Psychosocial interventions for reducing antipsychotic medication in care home residentsReview
      78. Reality orientation for dementiaReviewWithdrawn
      79. Reminiscence therapy for dementiaReview
      80. Respite care for people with dementia and their carersReview
      81. Rivastigmine for Alzheimer's diseaseReview
      82. Rivastigmine for vascular cognitive impairmentReview
      83. Selegiline for Alzheimer's diseaseReview
      84. Shunting for normal pressure hydrocephalus (NPH)Review
      85. Snoezelen for dementiaReview
      86. Special care units for dementia individuals with behavioural problemsReview
      87. Statins for the prevention of dementiaReview
      88. Statins for the treatment of dementiaReview
      89. Subjective barriers to prevent wandering of cognitively impaired peopleReview
      90. Support for carers of people with Alzheimer's type dementiaReviewWithdrawn
      91. Tacrine for Alzheimer's diseaseReviewWithdrawn
      92. Thiamine for Alzheimer's diseaseReview
      93. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuseReview
      94. Thioridazine for dementiaReview
      95. Transcutaneous Electrical Nerve Stimulation (TENS) for dementiaReview
      96. Trazodone for agitation in dementiaReview
      97. Validation therapy for dementiaReview
      98. Valproate preparations for agitation in dementiaReview
      99. Velnacrine for Alzheimer's diseaseReview
      100. Vinpocetine for cognitive impairment and dementiaReview
      101. Vitamin B12 for cognitionReview
      102. Vitamin B6 for cognitionReview
      103. Vitamin E for Alzheimer's dementia and mild cognitive impairmentReview
      104. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementiaReview
      105. Yizhi capsule for vascular dementiaReview
      106. Zhiling decoction for vascular dementiaReview
    3. Protocols
      1. 11C-PIB-PET for the early diagnosis of Alzheimer’s disease dementia and other dementias in people with mild cognitive impairment (MCI)ProtocolDiagnostic
      2. Antibiotics and antivirals for dementia and mild cognitive impairmentProtocol
      3. Assistive technology for memory support in dementiaProtocol
      4. Caffeine for cognitionProtocol
      5. Carbamazepine and oxcarbazepine for the treatment of behavioural and psychological symptoms of dementia (BPSD)Protocol
      6. Case/care management approaches to home support for people with dementiaProtocol
      7. Cerebrolysin for Alzheimer's diseaseProtocol
      8. Cholinesterase inhibitors for rarer dementiasProtocol
      9. Dimebon for Alzheimer's diseaseProtocol
      10. Efficacy and experiences of telephone counselling for informal carers of people with dementiaProtocol
      11. Endoscopic third ventriculostomy (ETV) for idiopathic normal pressure hydrocephalus (iNPH)Protocol
      12. Flow-regulated versus differential pressure-regulated shunt valves for adult patients with normal pressure hydrocephalusProtocol
      13. Ginkgo biloba for cognitive improvement in healthy individualsProtocol
      14. Information and support interventions for informal caregivers of people with dementiaProtocol
      15. Interventions for preventing delirium in older people in institutional long term careProtocol
      16. IQCODE for the diagnosis of Alzheimer’s disease dementia and other dementias within a community settingProtocolDiagnostic
      17. L-carnitine for cognition in healthy subjectsProtocol
      18. Multidisciplinary Team Interventions for the management of delirium in hospitalized patientsProtocol
      19. Neuropsychological tests for the diagnosis of Alzheimer’s disease dementia and other dementias: a generic protocol for cross-sectional and delayed-verification studiesProtocolDiagnostic
      20. Omega 3 fatty acids for the treatment of dementia and cognitive impairmentProtocol
      21. Opioids for agitation in dementiaProtocol
      22. Passive immunisation with monoclonal anti-Abeta antibodies for the treatment of Alzheimer's diseaseProtocol
      23. Personally-tailored activities for improving psychosocial outcomes for people with dementia in long-term careProtocol
      24. Pharmacotherapies for sleep disturbances in Alzheimer's diseaseProtocol
      25. Pharmacotherapy for chronic cognitive impairment in traumatic brain injuryProtocol
      26. Physical activity for improving cognition in older people with mild cognitive impairmentProtocol
      27. Plasma and CSF Abeta for the longitudinal prediction of Alzheimer's disease dementia and other dementias in people with cognitive decline but no dementiaProtocolDiagnostic
      28. Posatirelin (l-pyro-2-aminoadipyl-l-leucyl-l-prolinamide) treatment for persons with dementiaProtocol
      29. Psychological treatments for depression and anxiety in dementia and mild cognitive impairmentProtocol
      30. The role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)ProtocolDiagnostic
      31. Testosterone supplementation for mild cognitive impairment and dementiaProtocol
      32. Thiazolidinediones for dementia and mild cognitive impairmentProtocol
      33. Traditional Chinese herbal medicine for vascular dementiaProtocol
      34. Tramiprosate (Alzhemed) for Alzheimer's diseaseProtocol
      35. Withdrawal or continuation of cholinesterase inhibitors and/or memantine in patients with dementia.Protocol
  12. Cochrane Depression, Anxiety and Neurosis Group
  13. Cochrane Developmental, Psychosocial and Learning Problems Group
  14. Cochrane Drugs and Alcohol Group
  15. Cochrane Ear, Nose and Throat Disorders Group
  16. Cochrane Effective Practice and Organisation of Care Group
  17. Cochrane Epilepsy Group
  18. Cochrane Eyes and Vision Group
  19. Cochrane Fertility Regulation Group
  20. Cochrane Gynaecological Cancer Group
  21. Cochrane Haematological Malignancies Group
  22. Cochrane Heart Group
  23. Cochrane Hepato-Biliary Group
  24. Cochrane HIV/AIDS Group
  25. Cochrane Hypertension Group
  26. Cochrane Incontinence Group
  27. Cochrane Infectious Diseases Group
  28. Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Group
  29. Cochrane Injuries Group
  30. Cochrane Lung Cancer Group
  31. Cochrane Menstrual Disorders and Subfertility Group
  32. Cochrane Metabolic and Endocrine Disorders Group
  33. Cochrane Methodology Review Group
  34. Cochrane Movement Disorders Group
  35. Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group
  36. Cochrane Musculoskeletal Group
  37. Cochrane Neonatal Group
  38. Cochrane Neuromuscular Disease Group
  39. Cochrane Occupational Safety and Health Group
  40. Cochrane Oral Health Group
  41. Cochrane Pain, Palliative and Supportive Care Group
  42. Cochrane Peripheral Vascular Diseases Group
  43. Cochrane Pregnancy and Childbirth Group
  44. Cochrane Prostatic Diseases and Urologic Cancers Group
  45. Cochrane Public Health Group
  46. Cochrane Renal Group
  47. Cochrane Schizophrenia Group
  48. Cochrane Sexually Transmitted Infections Group
  49. Cochrane Skin Group
  50. Cochrane Stroke Group
  51. Cochrane Tobacco Addiction Group
  52. Cochrane Upper Gastrointestinal and Pancreatic Diseases Group
  53. Cochrane Wounds Group

SEARCH